292 related articles for article (PubMed ID: 24146979)
1. Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease.
Devi L; Ohno M
PLoS One; 2013; 8(10):e77335. PubMed ID: 24146979
[TBL] [Abstract][Full Text] [Related]
2. PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Neurobiol Aging; 2014 Oct; 35(10):2272-81. PubMed ID: 24889041
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms that lessen benefits of β-secretase reduction in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Transl Psychiatry; 2013 Jul; 3(7):e284. PubMed ID: 23880880
[TBL] [Abstract][Full Text] [Related]
4. Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice.
Devi L; Ohno M
PLoS One; 2010 Sep; 5(9):e12974. PubMed ID: 20886088
[TBL] [Abstract][Full Text] [Related]
5. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.
O'Connor T; Sadleir KR; Maus E; Velliquette RA; Zhao J; Cole SL; Eimer WA; Hitt B; Bembinster LA; Lammich S; Lichtenthaler SF; Hébert SS; De Strooper B; Haass C; Bennett DA; Vassar R
Neuron; 2008 Dec; 60(6):988-1009. PubMed ID: 19109907
[TBL] [Abstract][Full Text] [Related]
7. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
Devi L; Ohno M
Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
[TBL] [Abstract][Full Text] [Related]
8. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
Kimura R; Devi L; Ohno M
J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
[TBL] [Abstract][Full Text] [Related]
9. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
[TBL] [Abstract][Full Text] [Related]
10. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.
Mouton-Liger F; Paquet C; Dumurgier J; Bouras C; Pradier L; Gray F; Hugon J
Biochim Biophys Acta; 2012 Jun; 1822(6):885-96. PubMed ID: 22306812
[TBL] [Abstract][Full Text] [Related]
12. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits.
Ma T; Trinh MA; Wexler AJ; Bourbon C; Gatti E; Pierre P; Cavener DR; Klann E
Nat Neurosci; 2013 Sep; 16(9):1299-305. PubMed ID: 23933749
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease.
Devi L; Alldred MJ; Ginsberg SD; Ohno M
PLoS One; 2012; 7(3):e32792. PubMed ID: 22403710
[TBL] [Abstract][Full Text] [Related]
14. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
15. Gastrodin suppresses BACE1 expression under oxidative stress condition via inhibition of the PKR/eIF2α pathway in Alzheimer's disease.
Zhang JS; Zhou SF; Wang Q; Guo JN; Liang HM; Deng JB; He WY
Neuroscience; 2016 Jun; 325():1-9. PubMed ID: 26987953
[TBL] [Abstract][Full Text] [Related]
16. Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease.
Devi L; Alldred MJ; Ginsberg SD; Ohno M
Mol Brain; 2010 Nov; 3():34. PubMed ID: 21059265
[TBL] [Abstract][Full Text] [Related]
17. PERK and GCN2 contribute to eIF2alpha phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway.
Hamanaka RB; Bennett BS; Cullinan SB; Diehl JA
Mol Biol Cell; 2005 Dec; 16(12):5493-501. PubMed ID: 16176978
[TBL] [Abstract][Full Text] [Related]
18. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and promising therapeutics of Alzheimer disease through eIF2α pathway and correspondent kinases.
Moradi Majd R; Mayeli M; Rahmani F
Metab Brain Dis; 2020 Dec; 35(8):1241-1250. PubMed ID: 32681467
[TBL] [Abstract][Full Text] [Related]
20. Quercetin reduces eIF2α phosphorylation by GADD34 induction.
Hayakawa M; Itoh M; Ohta K; Li S; Ueda M; Wang MX; Nishida E; Islam S; Suzuki C; Ohzawa K; Kobori M; Inuzuka T; Nakagawa T
Neurobiol Aging; 2015 Sep; 36(9):2509-18. PubMed ID: 26070242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
